AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Azitra, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $1.38M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.6155 (−89.59%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Azitra, Inc. saw revenue fall 100.0% to $0 over fiscal 2025. Free cash flow was -$11.17M.
Revenue
$0
-100.0% vs. a year earlier
Operating income
-$12.35M
TTM Q2 2026
Free cash flow
-$11.17M
TTM Q2 2026
EPS, diluted
-$2.25
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $1.38M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.19
- Dividend yield
- –
- Free cash flow yield
- -809.66%
Fundamentals
- Revenue
- $0
- Net income
- -$12.27M
- EPS, diluted
- -$2.25
- Free cash flow
- -$11.17M
- Book value per share
- $0.38
- Diluted shares
- 19M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$12.35M
Net income
-$12.27M
EPS, diluted
–
Free cash flow
-$11.17M
Reported periodTrailing twelve months